Fries, F.; Kany, A.M.; Rasheed, S.; Hirsch, A.K.H.; Müller, R.; Herrmann, J.
Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24, 12791.
https://doi.org/10.3390/ijms241612791
AMA Style
Fries F, Kany AM, Rasheed S, Hirsch AKH, Müller R, Herrmann J.
Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. International Journal of Molecular Sciences. 2023; 24(16):12791.
https://doi.org/10.3390/ijms241612791
Chicago/Turabian Style
Fries, Franziska, Andreas M. Kany, Sari Rasheed, Anna K. H. Hirsch, Rolf Müller, and Jennifer Herrmann.
2023. "Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos" International Journal of Molecular Sciences 24, no. 16: 12791.
https://doi.org/10.3390/ijms241612791
APA Style
Fries, F., Kany, A. M., Rasheed, S., Hirsch, A. K. H., Müller, R., & Herrmann, J.
(2023). Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. International Journal of Molecular Sciences, 24(16), 12791.
https://doi.org/10.3390/ijms241612791